(EFC) Ellington Financial - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US28852N1090
Stock: Mortgage Securities, Loans, Asset Backed, Investments
Total Rating 32
Risk 64
Buy Signal -0.68
| Risk 5d forecast | |
|---|---|
| Volatility | 20.4% |
| Relative Tail Risk | 1.71% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.08 |
| Alpha | -10.79 |
| Character TTM | |
|---|---|
| Beta | 0.491 |
| Beta Downside | 0.417 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.86% |
| CAGR/Max DD | 0.83 |
EPS (Earnings per Share)
Revenue
Description: EFC Ellington Financial March 05, 2026
Ellington Financial Inc. (EFC) is a mortgage REIT that invests in a diverse portfolio of mortgage-related and other financial assets in the United States. The company acquires and manages various residential mortgage-backed securities (RMBS), including those backed by prime jumbo, Alt-A, and non-QM loans. Mortgage REITs typically finance their investments with borrowed capital, aiming to profit from the spread between their asset yields and funding costs.
EFCs investment strategy also extends to commercial mortgage-backed securities, consumer loans, and asset-backed securities. A significant portion of their business involves investments tied to mortgage servicing rights and collateralized loan obligations. The company operates through two segments: Investment Portfolio and Longbridge, the latter focusing on reverse mortgage loans. Mortgage REITs are legally obligated to distribute most of their taxable income to shareholders as dividends.
EFCs extensive asset classes, including non-agency RMBS and consumer loans, differentiate its investment profile within the mortgage REIT sector. Further research into its specific portfolio allocations and hedging strategies can provide deeper insights. The company was founded in 2007 and is based in Old Greenwich, Connecticut.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 146.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.04 > 0.02 and ΔFCF/TA -2.51 > 1.0 |
| NWC/Revenue: -530.1% < 20% (prev -959.1%; Δ 429.0% < -1%) |
| CFO/TA -0.04 > 3% & CFO -768.1m > Net Income 146.9m |
| Net Debt (-201.9m) to EBITDA (366.7m): -0.55 < 3 |
| Current Ratio: 0.08 > 1.5 & < 3 |
| Outstanding Shares: last quarter (99.4m) vs 12m ago 11.44% < -2% |
| Gross Margin: 77.83% > 18% (prev 0.53%; Δ 7730 % > 0.5%) |
| Asset Turnover: 2.60% > 50% (prev 1.73%; Δ 0.87% > 0%) |
| Interest Coverage Ratio: 0.31 > 6 (EBITDA TTM 366.7m / Interest Expense TTM 304.5m) |
Altman Z'' -0.89
| A: -0.13 (Total Current Assets 201.9m - Total Current Liabilities 2.66b) / Total Assets 19.35b |
| B: -0.02 (Retained Earnings -413.0m / Total Assets 19.35b) |
| C: 0.01 (EBIT TTM 93.3m / Avg Total Assets 17.83b) |
| D: -0.02 (Book Value of Equity -412.9m / Total Liabilities 17.48b) |
| Altman-Z'' Score: -0.89 = CCC |
Beneish M
| DSRI: 0.62 (Receivables 213.1m/211.3m, Revenue 462.8m/282.2m) |
| GMI: 0.69 (GM 77.83% / 53.35%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 1.64 (Revenue 462.8m / 282.2m) |
| TATA: 0.05 (NI 146.9m - CFO -768.1m) / TA 19.35b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of EFC shares?
As of March 07, 2026, the stock is trading at USD 12.03 with a total of 1,978,393 shares traded.
Over the past week, the price has changed by -3.14%, over one month by -6.50%, over three months by -8.96% and over the past year by +0.52%.
Over the past week, the price has changed by -3.14%, over one month by -6.50%, over three months by -8.96% and over the past year by +0.52%.
Is EFC a buy, sell or hold?
Ellington Financial has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy EFC.
- StrongBuy: 2
- Buy: 4
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the EFC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 14.6 | 21.6% |
| Analysts Target Price | 14.6 | 21.6% |
EFC Fundamental Data Overview March 03, 2026
P/E Trailing = 9.4091
P/E Forward = 9.0744
P/S = 4.694
P/B = 1.0798
P/EG = 0.86
Revenue TTM = 462.8m USD
EBIT TTM = 93.3m USD
EBITDA TTM = 366.7m USD
Long Term Debt = 13.50b USD (from longTermDebt, two quarters ago)
Short Term Debt = 2.66b USD (from shortTermDebt, last quarter)
Debt = 16.96b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -201.9m USD (from netDebt column, last quarter)
Enterprise Value = 18.31b USD (1.55b + Debt 16.96b - CCE 201.9m)
Interest Coverage Ratio = 0.31 (Ebit TTM 93.3m / Interest Expense TTM 304.5m)
EV/FCF = -23.84x (Enterprise Value 18.31b / FCF TTM -768.1m)
FCF Yield = -4.20% (FCF TTM -768.1m / Enterprise Value 18.31b)
FCF Margin = -166.0% (FCF TTM -768.1m / Revenue TTM 462.8m)
Net Margin = 31.73% (Net Income TTM 146.9m / Revenue TTM 462.8m)
Gross Margin = 77.83% ((Revenue TTM 462.8m - Cost of Revenue TTM 102.6m) / Revenue TTM)
Gross Margin QoQ = 79.28% (prev 80.50%)
Tobins Q-Ratio = 0.95 (Enterprise Value 18.31b / Total Assets 19.35b)
Interest Expense / Debt = 0.51% (Interest Expense 86.6m / Debt 16.96b)
Taxrate = 2.45% (3.79m / 154.6m)
NOPAT = 91.0m (EBIT 93.3m * (1 - 2.45%))
Current Ratio = 0.08 (Total Current Assets 201.9m / Total Current Liabilities 2.66b)
Debt / Equity = 9.25 (Debt 16.96b / totalStockholderEquity, last quarter 1.83b)
Debt / EBITDA = -0.55 (Net Debt -201.9m / EBITDA 366.7m)
Debt / FCF = 0.26 (negative FCF - burning cash) (Net Debt -201.9m / FCF TTM -768.1m)
Total Stockholder Equity = 1.72b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.82% (Net Income 146.9m / Total Assets 19.35b)
RoE = 8.54% (Net Income TTM 146.9m / Total Stockholder Equity 1.72b)
RoCE = 0.61% (EBIT 93.3m / Capital Employed (Equity 1.72b + L.T.Debt 13.50b))
RoIC = 0.56% (NOPAT 91.0m / Invested Capital 16.34b)
WACC = 1.10% (E(1.55b)/V(18.51b) * Re(7.73%) + D(16.96b)/V(18.51b) * Rd(0.51%) * (1-Tc(0.02)))
Discount Rate = 7.73% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 17.41%
[DCF] Fair Price = unknown (Cash Flow -768.1m)
EPS Correlation: 22.80 | EPS CAGR: 4.39% | SUE: 0.30 | # QB: 0
Revenue Correlation: 59.70 | Revenue CAGR: 135.1% | SUE: 2.38 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.45 | Chg7d=-0.003 | Chg30d=-0.014 | Revisions Net=+0 | Analysts=6
EPS current Year (2026-12-31): EPS=1.81 | Chg7d=-0.007 | Chg30d=-0.044 | Revisions Net=+5 | Growth EPS=-2.6% | Growth Revenue=+27.1%
EPS next Year (2027-12-31): EPS=1.90 | Chg7d=-0.006 | Chg30d=-0.006 | Revisions Net=+2 | Growth EPS=+5.1% | Growth Revenue=+2.8%
[Analyst] Revisions Ratio: +1.00 (5 Up / 0 Down within 30d for Current Year)
[Growth] Implied Growth Rate = -2.7% (Discount Rate 7.9% - Earnings Yield 10.6%)
[Growth] Growth Spread = +36.8% (Analyst 34.1% - Implied -2.7%)
P/E Forward = 9.0744
P/S = 4.694
P/B = 1.0798
P/EG = 0.86
Revenue TTM = 462.8m USD
EBIT TTM = 93.3m USD
EBITDA TTM = 366.7m USD
Long Term Debt = 13.50b USD (from longTermDebt, two quarters ago)
Short Term Debt = 2.66b USD (from shortTermDebt, last quarter)
Debt = 16.96b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -201.9m USD (from netDebt column, last quarter)
Enterprise Value = 18.31b USD (1.55b + Debt 16.96b - CCE 201.9m)
Interest Coverage Ratio = 0.31 (Ebit TTM 93.3m / Interest Expense TTM 304.5m)
EV/FCF = -23.84x (Enterprise Value 18.31b / FCF TTM -768.1m)
FCF Yield = -4.20% (FCF TTM -768.1m / Enterprise Value 18.31b)
FCF Margin = -166.0% (FCF TTM -768.1m / Revenue TTM 462.8m)
Net Margin = 31.73% (Net Income TTM 146.9m / Revenue TTM 462.8m)
Gross Margin = 77.83% ((Revenue TTM 462.8m - Cost of Revenue TTM 102.6m) / Revenue TTM)
Gross Margin QoQ = 79.28% (prev 80.50%)
Tobins Q-Ratio = 0.95 (Enterprise Value 18.31b / Total Assets 19.35b)
Interest Expense / Debt = 0.51% (Interest Expense 86.6m / Debt 16.96b)
Taxrate = 2.45% (3.79m / 154.6m)
NOPAT = 91.0m (EBIT 93.3m * (1 - 2.45%))
Current Ratio = 0.08 (Total Current Assets 201.9m / Total Current Liabilities 2.66b)
Debt / Equity = 9.25 (Debt 16.96b / totalStockholderEquity, last quarter 1.83b)
Debt / EBITDA = -0.55 (Net Debt -201.9m / EBITDA 366.7m)
Debt / FCF = 0.26 (negative FCF - burning cash) (Net Debt -201.9m / FCF TTM -768.1m)
Total Stockholder Equity = 1.72b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.82% (Net Income 146.9m / Total Assets 19.35b)
RoE = 8.54% (Net Income TTM 146.9m / Total Stockholder Equity 1.72b)
RoCE = 0.61% (EBIT 93.3m / Capital Employed (Equity 1.72b + L.T.Debt 13.50b))
RoIC = 0.56% (NOPAT 91.0m / Invested Capital 16.34b)
WACC = 1.10% (E(1.55b)/V(18.51b) * Re(7.73%) + D(16.96b)/V(18.51b) * Rd(0.51%) * (1-Tc(0.02)))
Discount Rate = 7.73% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 17.41%
[DCF] Fair Price = unknown (Cash Flow -768.1m)
EPS Correlation: 22.80 | EPS CAGR: 4.39% | SUE: 0.30 | # QB: 0
Revenue Correlation: 59.70 | Revenue CAGR: 135.1% | SUE: 2.38 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.45 | Chg7d=-0.003 | Chg30d=-0.014 | Revisions Net=+0 | Analysts=6
EPS current Year (2026-12-31): EPS=1.81 | Chg7d=-0.007 | Chg30d=-0.044 | Revisions Net=+5 | Growth EPS=-2.6% | Growth Revenue=+27.1%
EPS next Year (2027-12-31): EPS=1.90 | Chg7d=-0.006 | Chg30d=-0.006 | Revisions Net=+2 | Growth EPS=+5.1% | Growth Revenue=+2.8%
[Analyst] Revisions Ratio: +1.00 (5 Up / 0 Down within 30d for Current Year)
[Growth] Implied Growth Rate = -2.7% (Discount Rate 7.9% - Earnings Yield 10.6%)
[Growth] Growth Spread = +36.8% (Analyst 34.1% - Implied -2.7%)